Summer is in full swing, and our most important event of the year draws near. In this special edition of our editorial, we want to update you on our conference and what we have in store for you this year.
Can we turn back our biological clocks?
Life Noggin has teamed up with with Trudiagnostic to make a video about biological age and how we can measure it using aging clocks.
Being able to accurately measure a person’s biological age is very important in the race to develop technology that can address the aging processes. This is because if we cannot see any changes to our biological age following a treatment, we will not know if it has worked or not.
Thanks to Trudiagnostic for sponsoring this video, and if you would like to find out how you can sponsor a video, please get in touch.
How Life Noggin educates millions about science
Continuing with the Life Noggin theme, we have an exclusive interview with Pat Graziosi, the man behind the show and the voice of the main character, Blocko. In this interview, we delve into Graziosi’s incredible journey, starting from his early days of creating skits on Google Video to his current success as the creator of a YouTube series that has captivated millions of viewers.
During the interview, Graziosi opens up about his creative process, shedding light on the inspiration that brought his iconic characters to life and explaining why he opted for a simple animation style. He also shares the fascinating story behind the birth of Blocko. Moreover, Graziosi discusses the highs and lows of being a content creator and the challenges he faces in keeping up with the ever-changing YouTube algorithm, all while staying true to his authentic self.
The conversation doesn’t stop there. Graziosi also reveals his passion for advancements in medical technology and his commitment to creating content that promotes healthier, happier, and longer lives.
Also, as a special summer deal, the Life Noggin team is offering 20% off of the price of regular and online tickets for our upcoming conference, Ending Age-Related Diseases 2023. You can get your discount using the code: keeponthinking.
Ending Age-Related Diseases 2023 is almost here!
We are delighted to announce our sixth Ending Age-Related Diseases conference on August 10-11 at the Capitale building in New York City and online.
With many interventions against aging already in human clinical trials, the rejuvenation industry seems to be reaching the stage of bearing fruit. However, much has yet to be done before our society can benefit from scientific progress in this field. We are bringing together experts in aging and rejuvenation research, biotech investment, policy, investment, and decentralized science (DeSci) to foster scientific and business collaborations in to accelerate the development of therapies that target the causes of aging.
We are also delighted to welcome the Advanced Research Projects Agency for Health (ARPA-H) to the conference this year. You can find out more about them and how they are helping to accelerate progress below.
There will be talks, workshops, and discussion panels, among other things to enjoy. Join us for two exciting days focused on how we can end age-related diseases sooner!
Conference speakers and program
Like in previous years, we have an action-packed schedule and have included a link to the conference program below. Check out the full list of confirmed speakers; below is just a small sample.
Brian Kennedy, Ph.D.
National University Singapore - Professor of Biochemistry and Physiology
Hanadie Yousef, Ph.D.
Juvena Therapeutics - CEO
Vadim Gladyshev, Ph.D.
Harvard Medical School - Professor, Medicine, Harvard Medical School
Matthew O'Connor, Ph.D.
Cyclarity Therapeutics - CEO of Scientific Affairs
Steve Horvath, Ph.D.
Altos Labs - Principal Investigator San Diego Institute of Science
Susan Monarez, Ph.D.
ARPA-H - Deputy Director
The Advanced Research Projects Agency for Health will be joining us
This year, ARPA-H, the Advanced Research Projects Agency for Health, is going to be at the conference. ARPA-H is a US government research funding agency modeled after DARPA (Defense Advanced Research Projects Agency). ARPA-H is committed to supporting high-impact research to drive transformative, sustainable, and equitable biomedical and health breakthroughs for everyone.
This organization is seeking the most innovative approaches to tackle the most challenging health issues, leveraging advances in research for real world impact, and you have the opportunity to be a part of it. Don’t miss the exclusive Program Manager 101 Workshop taking place at EARD 2023, where ARPA-H will share insights, answer questions, and debunk misconceptions about the programs they are looking to fund, what it takes to be a program manager, and more. Be part of this transformative event, and shape the future of healthcare and biomedical innovation.
Lots to look forward to at Ending Age-Related Diseases 2023
We have pulled out all the stops this year to make this our best conference yet. We have a great program of events this year; below are some of the highlights.
First up is a discussion panel exploring if aging can truly be reversed or not. Lifespan.io’s Vice President Oliver Medvedik chairs what is sure to be a robust and entertaining discussion panel featuring Peter Fedichev from GERO, Reason from Repair Biotechnologies and the Fight Aging blog, Hanadie Yousef from Juvena Therapeutics, Hans Keirstead from Immunis, and last but not least, Aubrey de Grey from the LEV Foundation.
Some researchers like Peter Fedichev believe that slowing down or halting aging is more likely to result from current research before rejuvenation, which he explains along with his theory of aging in a recent interview.
On the other hand, Aubrey de Grey believes that rejuvenation is posssible if we approach the problem from a damage repair position and directly tackle the reasons we age. It should be an interesting discussion, and perhaps these two ideas may find a productive middle ground during the panel.
Steve Horvath’s talk, Epigenetic Clocks to Identify Novel Anti-Aging Interventions, is another highlight. Horvath has been working on increasingly more accurate methylation clocks that can measure the biological age of a person. Developing reliable aging biomarkers helps us to determine if an intervention against any of the aging processes has been successful or not and will be critical in getting potential rejuvenation treatments through human trials.
Staying on the subject of biomarkers is another of our discussion panels, which will be exploring the process of establishing accurate biomarkers of aging. Oliver Medvedik once again chairs this panel with Lifespan.io President Keith Comito, Vadim Gladychev from Harvard Medical School, Maximilian Unfried from VitaDAO, and Mahdi Moqri from Harvard Medical School.
There are currently a number of biomarkers used to measure how someone is aging, but most if not all have their shortcomings. What is needed is a cost effective and accurate panel of biomarkers to determine if an approach has worked on not.
Without being able to demonstrate that a treatment has worked to modify age-related diseases and show that it has achieved this by directly targeting one or more of the aging processes, it will not be possible to get such things into the healthcare system and available for us to use. This panel promises to be an interesting discussion about the challenges and way ahead in developing those much needed aging biomarkers.
You can here, or if you prefer, you can visit the ticket page on Eventbrite. If you are in education and would like to attend, we are offering a special student discount this year. You can learn more about the event by visiting the Ending Age-Related Diseases 2023 page. Use keeponthinking to get 20% off the price of regular tickets.
We look forward to seeing you in New York City or online!
